BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 1793204)

  • 1. T cell vaccination in autoimmune diseases.
    Beraud E
    Ann N Y Acad Sci; 1991 Dec; 636():124-34. PubMed ID: 1793204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination against experimental autoimmune encephalomyelitis using a subencephalitogenic dose of autoimmune effector T cells. (2). Induction of a protective anti-idiotypic response.
    Lider O; Beraud E; Reshef T; Friedman A; Cohen IR
    J Autoimmun; 1989 Feb; 2(1):87-99. PubMed ID: 2568841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-idiotypic network induced by T cell vaccination against experimental autoimmune encephalomyelitis.
    Lider O; Reshef T; Beraud E; Ben-Nun A; Cohen IR
    Science; 1988 Jan; 239(4836):181-3. PubMed ID: 2447648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenic and non-pathogenic T lymphocytes specific for the encephalitogenic epitope of myelin basic protein: functional characteristics and vaccination properties.
    Beraud E; Balzano C; Zamora AJ; Varriale S; Bernard D; Ben-Nun A
    J Neuroimmunol; 1993 Aug; 47(1):41-53. PubMed ID: 7690770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of experimental autoimmune encephalomyelitis in Lewis rats by antibodies against CD2.
    Jung S; Toyka K; Hartung HP
    Eur J Immunol; 1995 May; 25(5):1391-8. PubMed ID: 7539758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of 15-deoxyspergualin on effector cells in experimental autoimmune diseases of the nervous system in the Lewis rat.
    Jung S; Toyka KV; Hartung HP
    Clin Exp Immunol; 1994 Dec; 98(3):494-502. PubMed ID: 7527745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mercury-induced autoreactive anti-class II T cell line protects from experimental autoimmune encephalomyelitis by the bias of CD8+ antiergotypic cells in Lewis rats.
    Castedo M; Pelletier L; Rossert J; Pasquier R; Villarroya H; Druet P
    J Exp Med; 1993 Apr; 177(4):881-9. PubMed ID: 8096239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Regulatory T cell network].
    Yamamura T
    Nihon Rinsho; 1994 Nov; 52(11):2805-10. PubMed ID: 7996672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic vaccination against adjuvant arthritis using autoimmune T cells treated with hydrostatic pressure.
    Lider O; Karin N; Shinitzky M; Cohen IR
    Proc Natl Acad Sci U S A; 1987 Jul; 84(13):4577-80. PubMed ID: 2955411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell vaccination induces the elimination of EAE effector T cells: analysis using GFP-transduced, encephalitogenic T cells.
    Volovitz I; Marmor Y; Mor F; Flügel A; Odoardi F; Eisenbach L; Cohen IR
    J Autoimmun; 2010 Sep; 35(2):135-44. PubMed ID: 20580204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell vaccination prevents EAE effector cell development but does not inhibit priming of MBP responsive cells.
    Bouwer HG; Hinrichs DJ
    J Neurosci Res; 1996 Aug; 45(4):455-62. PubMed ID: 8872906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental autoimmune panencephalitis and uveoretinitis transferred to the Lewis rat by T lymphocytes specific for the S100 beta molecule, a calcium binding protein of astroglia.
    Kojima K; Berger T; Lassmann H; Hinze-Selch D; Zhang Y; Gehrmann J; Reske K; Wekerle H; Linington C
    J Exp Med; 1994 Sep; 180(3):817-29. PubMed ID: 7520474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of V beta 8.2 CDR3 sequences from spinal cord T cells of Lewis rats vaccinated or treated with TCR V beta 8.2-39-59 peptide.
    Buenafe AC; Vainiene M; Celnik B; Vandenbark AA; Offner H
    J Immunol; 1995 Aug; 155(3):1556-64. PubMed ID: 7636217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypes of T cells infiltrating the eyes in autoimmune anterior uveitis associated with EAE.
    Zhang X; Jiang S; Manczak M; Sugden B; Adamus G
    Invest Ophthalmol Vis Sci; 2002 May; 43(5):1499-508. PubMed ID: 11980866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of experimental autoimmune uveoretinitis by low dose T cell vaccination.
    Beraud E; Kotake S; Caspi RR; Oddo SM; Chan CC; Gery I; Nussenblatt RB
    Cell Immunol; 1992 Mar; 140(1):112-22. PubMed ID: 1739982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of experimental autoimmune encephalomyelitis by T cells responding to activated T cells.
    Lohse AW; Mor F; Karin N; Cohen IR
    Science; 1989 May; 244(4906):820-2. PubMed ID: 2471264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory circuits in autoimmunity: recruitment of counter-regulatory CD8+ T cells by encephalitogenic CD4+ T line cells.
    Sun D; Ben-Nun A; Wekerle H
    Eur J Immunol; 1988 Dec; 18(12):1993-9. PubMed ID: 2905995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional heterogeneity among CD4+ encephalitogenic T cells in recruitment of CD8+ T cells in experimental autoimmune encephalomyelitis.
    Sun D; Klinkert WE
    J Immunol; 1989 Nov; 143(9):2867-72. PubMed ID: 2478627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A myelin basic protein-specific T lymphocyte line that mediates experimental autoimmune encephalomyelitis.
    Vandenbark AA; Gill T; Offner H
    J Immunol; 1985 Jul; 135(1):223-8. PubMed ID: 2582032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of experimental autoimmune encephalomyelitis in Lewis rats by nasal administration of encephalitogenic MBP peptides: synergistic effects of MBP 68-86 and 87-99.
    Liu JQ; Bai XF; Shi FD; Xiao BG; Li HL; Levi M; Mustafa M; Wahren B; Link H
    Int Immunol; 1998 Aug; 10(8):1139-48. PubMed ID: 9723700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.